552
Views
1
CrossRef citations to date
0
Altmetric
Perspective

Applications of High-Resolution MS in Bioanalysis

, &
Pages 1269-1276 | Published online: 30 May 2013

References

  • Maurer HH . Perspectives of liquid chromatography coupled to low- and high-resolution mass spectrometry for screening, identification, and quantification of drugs in clinical and forensic toxicology. Ther. Drug Monit. 32, 324–327 (2010).
  • Zhu M , MaL, ZhangDet al. Detection and characterization of metabolites in biological matrices using mass defect filtering of liquid chromatography/high resolution mass spectrometry data. Drug Metab. Dispos. 34, 1722–1733 (2006).
  • Zhu M , MaL, ZhangH, HumphreysWG. Detection and structural characterization of glutathione-trapped reactivemetabolites using liquid chromatography–high-resolution mass spectrometry and mass defect filtering. Anal. Chem. 79, 8333–8341 (2007).
  • Ma S , ZhuM. Recent advances in applications of liquid chromatography–tandem mass spectrometry to the analysis of reactive drug metabolites. Chem. Biol. Interact. 179, 25–37 (2009).
  • Zhang H , ZhangD, RayK, ZhuM. Mass defect filter technique and its applications to drug metabolite identification by high-resolution mass spectrometry. J. Mass Spectrom. 44, 999–1016 (2009).
  • Jemal M . High-throughput quantitative bioanalysis by LC–MS/MS. Biomed. Chromatogr. 14, 422–429 (2000).
  • Henion J , BrewerE, RuleG. Preparation for LC–MS/MS: analyzing biological and environmental samples – knowing the basic requirements and the big picture of an LC–MS system can ensure success in most instances. Anal. Chem. 70, 650A–656A (1998).
  • Weng N , ChenYL, ShouW, JiangX. Importance of injection solution composition for LC–MS/MS methods. J. Pharm. Biomed. Anal. 26, 753–767 (2001).
  • Korfmacher W . Principles and applications of LC–MS in new drug discovery. Drug Discov. Today10, 1357–1367 (2005).
  • Zhou S , SongQ, TangY, WengN. Critical review of development, validation, and transfer for high throughput bioanalytical LC–MS/MS methods. Curr. Pharm. Anal. 1, 3–14 (2005).
  • Korfmacher W . High-resolution mass spectrometry will dramatically change our drug-discovery bioanalytical procedures. Bioanalysis3, 1169–1171 (2011).
  • Josephs JL . HRMS: current usage, future directions and the promise of integration with unified data streams suited to post-acquisition mining. Bioanalysis4, 471–476 (2012).
  • Ma S , ChowdhurySK. Application of LC-high-resolution MS with ‘intelligent’ data mining tools for screening reactive drug metabolites. Bioanalysis4, 501–510 (2012).
  • Campbell JL , Le Blanc JC. Using high-resolution quadrupole TOF technology in DMPK analyses. Bioanalysis4, 487–500 (2012).
  • Miller VP . SPE-MS analysis of absorption, distribution, metabolism and excretion assays: a tool to increase throughput and streamline workflow. Bioanalysis4, 111–1121 (2012).
  • Ramanathan R , KorfmacherW. The emergence of high-resolution MS as the premier analytical tool in the pharmaceutical bioanalysis arena. Bioanalysis4, 467–469 (2012).
  • Andrews GL , SimonsBL, YoungJB, HawkridgeAM, MuddimanDC. Performance characteristics of a new hybrid quadrupole time-of-flight tandem mass spectrometer (TripleTOF® 5600). Anal. Chem. 83, 5442–5446 (2011).
  • Junot C , MadalinskiG, TabetJC, EzanE. Fourier transform mass spectrometry for metabolome analysis. Analyst135, 2203–2219 (2010).
  • Makarov A , ScigelovaM. Coupling liquid chromatography to Orbitrap mass spectrometry. J. Chromatogr. A1217, 3938–3945 (2010).
  • Scigelova M , MakarovA. Advances in bioanalytical LC–MS using the Orbitrap mass analyzer. Bioanalysis1, 741–754 (2009).
  • Zhang NR , YuS, TillerP, YehS, MahanE, EmaryWB. Quantitation of small molecules using high-resolution accurate mass spectrometers-a different approach for analysis of biological samples. Rapid Commun. Mass Spectrom. 23, 1085–1094 (2009).
  • Bateman KP , KellmannM, MuensterH, PappR, TaylorcL. Quantitative–qualitative data acquisition using a benchtop Orbitrap mass spectrometer. J. Am. Soc. Mass Spectrom. 20, 1441–1450 (2009).
  • Kaufmann A , ButcherP, MadenK, WalkerS, WidmerM. Quantitative and confirmative performance of liquid chromatography coupled to high-resolution mass spectrometry compared to tandem mass spectrometry. Rapid Commun. Mass Spectrom. 25, 979–992 (2011).
  • Kaufmann A , WidmerM, MadenK. Post-interface signal suppression, a phenomenon observed in a single-stage Orbitrap mass spectrometer coupled to an electrospray interfaced liquid chromatograph. Rapid Commun. Mass Spectrom. 24, 2162–2170 (2010).
  • Xia YQ , LauJ, OlahT, JemalM. Targeted Quantitative bioanalysis in plasma using liquid chromatography/high-resolution accurate mass spectrometry: an evaluation of global selectivity as a function of mass resolving power and extraction window, with comparison of centroid and profile modes. Rapid Commun. Mass Spectrom. 25, 2863–2878 (2011).
  • Wei C , GraceJE, ZvyagaTA, DrexlerDM. Utility of high-resolution accurate MS to eliminate interferences in the bioanalysis of ribavirin and its phosphate metabolites. Bioanalysis4, 1895–1905 (2012).
  • Ramanathan R , JemalM, RamagiriSet al. It is time for a paradigm shift in drug discovery bioanalysis: from SRM to HRMS. J. Mass Spectrom. 46, 595–601 (2011).
  • Ranasinghe A , RamanathanR, JemalMet al. Integrated quantitative and qualitative workflow for in vivo bioanalytical support in drug discovery using hybrid Q-TOF-MS. Bioanalysis4, 511–528 (2012).
  • Zhang J , MaloneyJ, DrexlerDMet al. Cassette incubation followed by bioanalysis using high-resolution MS for in vitro ADME screening assays. Bioanalysis4, 581–593 (2012).
  • Fung EN , XiaYQ, AubryAF, ZengJ, OlahT, JemalM. Full-scan high resolution accurate mass spectrometry (HRMS) in regulated bioanalysis: LC–HRMS for the quantitation of prednisone and prednisolone in human plasma. J. Chromatogr. B. 879, 2919–2927 (2011).
  • Han B , CopelandM, GeiserAGet al. Development of a highly sensitive, high-throughput, mass spectrometry-based assay for rat procollagen type-I N-terminal propeptide (PINP) to measure bone formation activity. J. Proteome Res. 6, 4218–4229 (2007).
  • Ji C , SadagopanN, ZhangY, LepsyC. A universal strategy for development of a method for absolute quantification of therapeutic monoclonal antibodies in biological matrices using differential dimethyl labeling coupled with ultra performance liquid chromatography–tandem mass spectrometry. Anal. Chem. 81, 9321–9328 (2009).
  • Hoofnagle AN , WenerMH. The fundamental flaws of immunoassays and potential solutions using tandem mass spectrometry. J. Immunol. Methods347, 3–11 (2009).
  • Wu ST , OuyangZ, OlahTV, JemalML. A strategy for liquid chromatography/tandem mass spectrometry based quantitation of pegylated protein drugs in plasma using plasma protein precipitation with water-miscible organic solvents and subsequent trypsin digestion to generate surrogate peptides for detection. Rapid Commun. Mass Spectrom. 25, 281–290 (2011).
  • Plumb RS , FujimotoG, MatherJet al. Comparison of the quantification of a therapeutic protein using nominal and accurate mass MS/MS. Bioanalysis4, 605–615 (2012).
  • Dillen L , CoolsW, VereykenLet al. Comparison of triple quadrupole and high-resolution TOF-MS for quantification of peptides. Bioanalysis4, 565–579 (2012).
  • Ramagiri S , GarofoloF. Large molecule bioanalysis using Q-TOF without predigestion and its data processing challenges. Bioanalysis4, 529–540 (2012).
  • Ruan Q , JiQC, ArnoldME, HumphreysWG, ZhuM. Strategy and its implications of protein bioanalysis utilizing high-resolution mass spectrometric detection of intact protein. Anal. Chem. 83, 8937–8944 (2011).
  • Ji QC , RodilaR, GageEM, EL-ShourbagyTA. A strategy of plasma protein quantitation by selective reaction monitoring of an intact protein. Anal. Chem. 75, 7008–7014 (2003).
  • Ji QC , RodilaR, MorganS, HumerickhouseRA, EL-ShourbagyTA. Investigation of the immunogenicity of a protein drug using equilibrium dialysis and liquid chromatography tandem mass spectrometry detection. Anal. Chem. 77, 5529–5533 (2005).
  • Gucinski AC , BoyneII MT. Evaluation of intact mass spectrometry for the quantitative analysis of protein therapeutics. Anal. Chem. 84, 8045–8051 (2011).
  • Jian W , EdomRW, WangD, WengN, ZhangS. Relative quantitation of glycoisoforms of intact apolipoprotein C3 in human plasma by liquid chromatography–high-resolution mass spectrometry. Anal. Chem. 85, 2867–2874 (2013).
  • Lin ZJ , LiW, DaiG. Application of LC–MS for quantitative analysis and metabolite identification of therapeutic oligonucleotides. J. Pharm. Biomed. Anal. 44, 330–341 (2007).
  • Hopfgartner G , VaresioE. New approaches for quantitative analysis in biological fluids using mass spectrometric detection. Trends Anal. Chem. 24, 583–589 (2005).
  • Jian W , EdomR, WengN, ZannikosP, ZhangZ, WangH. Validation and application of an LC–MS/MS method for quantitation of three fatty acid ethanolamides as biomarkers for fatty acid hydrolase inhibition in human plasma. J. Chromatogr. B878, 1687–1699 (2010).
  • Jian W , EdomRW, WengN. Important considerations for quantitation of biomarkers using liquid chromatography and mass spectrometry (LC–MS), Bioanalysis4, 2431–2434 (2012).
  • Jemal M , XiaYQ. LC–MS development strategies for quantitative bioanalysis, Curr. Drug Metab. 7, 491–502 (2006).
  • Gao S , ZhangZP, KarnesHT. Sensitivity enhancement in liquid chromatography/atmospheric pressure ionization mass spectrometry using derivatization and mobile phase additives, J. Chromatogr. B825, 98–110 (2005).
  • Zhu LS , LapkoVN, LeeJWet al. A General approach for the quantitative analysis of bisphosphonates in human serum and urine by high-performance liquid chromatography/tandem mass spectrometry. Rapid Commun. Mass Spectrom. 20, 3421–3426 (2006).
  • Li W , LiYH, LiAC, ZhouS, WengN. Simultaneous determination of norethindrone and ethinyl estradiol in human plasma by high performance liquid chromatography with tandem mass spectrometry – experiences on developing a highly selective method using derivatization reagent for enhancing sensitivity. J. Chromatogr. B825, 223–232 (2005).

Website

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.